Join

Compare · HLN vs SHOT

HLN vs SHOT

Side-by-side comparison of Haleon plc (HLN) and Safety Shot Inc. (SHOT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HLN and SHOT operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
  • HLN carries a market cap of $39.59B.
  • Over the past year, HLN is down 18.3% and SHOT is up 43.0% - SHOT leads by 61.2 points.
  • HLN has hit the wire 11 times in the past 4 weeks while SHOT has been quiet.
  • HLN has more recent analyst coverage (19 ratings vs 0 for SHOT).
PerformanceHLN-17.42%SHOT+42.98%
2026-02-04+0.00%2026-06-08
MetricHLNSHOT
Company
Haleon plc
Safety Shot Inc.
Price
$8.89-2.41%
$0.38-8.64%
Market cap
$39.59B
-
1M return
-4.46%
-1.03%
1Y return
-18.25%
+42.98%
Industry
Package Goods/Cosmetics
Package Goods/Cosmetics
Exchange
NYSE
NASDAQ
IPO
2022
2020
News (4w)
11
0
Recent ratings
19
0
HLN

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.